Human EGFR2(Epidermal Growth Factor Receptor 2) ELISA Kit
Human EGFR2(Epidermal Growth Factor Receptor 2) ELISA Kit with collaborator-tested sample matrix evidence from Elabscience. Read more ›
["Standard curve"]Product Description
EGFR2 is the stated analyte for this Elabscience immunoassay kit. The product is listed by ABMIUM using collaborator-supplied specifications for research-use-only quantification workflows.
Assay profile: assay type: Traditional ELISA Kits; detection method: Colorimetric method,ELISA,Sandwich; format: 48Tests.
Performance information: sensitivity: 18.75 pg/mL; standard curve range: 31.25-2000 pg/mL; assay duration: 3 h 30 min.
Sample matrix: Elabscience lists Serum, plasma and other biological fluids. These listed sample types are marked C in the ABMIUM sample validation matrix as collaborator-tested ABMIUM Verified evidence. Common unlisted sample types are retained as N where the supplied file does not provide supporting data.
Database references: UniProt: P04626 | NCBI Gene: 2064 | Gene symbol: EGFR2.
Research Use Only.
Key Facts
| Target | EGFR2 |
| Also known as | ERBB2,CD340,HER-2,HER-2/neu,HER2,MLN 19,NEU,NGL,TKR1,erb-b2 receptor tyrosine kinase 2,HER2/ErbB2,MLN19,Receptor tyrosine-protein kinase erbB-2,Tyrosine kinase-type cell surface receptor HER2 |
| Shelf life | 12 months from shipping dates |
| Research area | Cancer, Immunology, Signal transduction, Tags and Cell Markers |
| Assay type | Traditional ELISA Kits |
| Detection method | Colorimetric method,ELISA,Sandwich |
| Plate format | 48-well microplate plates pre-coated with anti-EGFR2 capture antibody |
Sample Type Validation
1 sample type| Sample Type | SERUM | PLASMA (EDTA) | URINE | CSF | CELL SUPERNATANT |
|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.